Christopher Fenimore

Christopher Fenimore

Director of Finance/CFO at REGENERON PHARMACEUTICALS, INC.

Net worth: 14 M $ as of 29/06/2026

55 year
Consumer Services
Commercial Services
Health Technology

Profile

Christopher Robert Fenimore is currently Director at Regeneron UK Ltd. since 2014 and Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. since 2024.
Former positions include Senior Audit at KPMG Holding AG and Vice President-Finance at Mojave Therapeutics, Inc. from 2000 to 2003.
Education includes graduate degrees from The Trustees of Columbia University in The City of New York, an undergraduate degree from Rutgers State University of New Jersey in 1992, and an MBA from Rutgers Business School in 1993.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/04/2026 21,797 ( 0.02% ) 14 M $ 29/06/2026

Christopher Fenimore active positions

CompaniesPositionStart
REGENERON PHARMACEUTICALS, INC. Director of Finance/CFO 04/02/2024
Director/Board Member 17/07/2014

Former positions of Christopher Fenimore

CompaniesPositionEnd
Mojave Therapeutics, Inc.
Corporate Officer/Principal 31/12/2002
Corporate Officer/Principal -
See the detail of Christopher Fenimore's experience

Training of Christopher Fenimore

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Commercial Services

Mojave Therapeutics, Inc.

Consumer Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Christopher Fenimore